Outcomes were evaluated using chi-square/Fisher's exact tests and multivariable logistic regression.<h4>Results</h4>Two hundred forty-seven adults prescribed GLP-1 for obesity who lost coverage (mean age 49.27 years-SD: 9.89, BMI 32.85 kg/m<sup>2</sup>-SD: 8.49); 90.28% were female, 40.08% non-Hispanic White, 30.36% non-Hispanic Black, 19.84% Hispanic, and 9.72% Other. Here, GLP1R is linked to obesity disorder.